| Product Name | MF | CAS | Details |
|---|
| Dihydromyristicin | C11H14O3 | 52811-28-6 | Details |
| Thalidomide-NH-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2460022-53-9 | Details |
| Pomalidomide-5-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2863635-00-9 | Details |
| Eledoisin Related Peptide 2TFA | C34H58N8O6S | Details |
| Asp-Asp-Asp-Asp-Asp-Asp | C24H32N6O19 | 145224-96-0 | Details |
| GBT1118 | C19H20N2O4 | 1628799-51-8 | Details |
| TFLLR-NH2 2TFA(197794-83-5(free base)) | C31H53N9O6 | Details |
| Demethylcantharidate disodium | C8H11NaO5 | 129-67-9 | Details |
| NLRP3-IN-17 | C21H22N4O2S | 2254432-75-0 | Details |
| S07-1066 | C16H11Cl2FO2 | 876625-29-5 | Details |
| PU-48 | C14H12N2O3S | 335394-78-0 | Details |
| Lepzacitinib | C18H21N5O3 | 2321488-47-3 | Details |
| CYP11A1-IN-1 | C27H34N2O5 | 2744168-51-0 | Details |
| Ilaprazole sodium hydrate | C19H21N4NaO3S | 2322264-11-7 | Details |
| MuRF1-IN-2 | C23H22N2O7 | 937891-74-2 | Details |
| AMX12006 | C26H22F3N3O3 | 2639775-01-0 | Details |
| SARS-CoV-2 nsp14-IN-3 | C17H17N3O3S | 2920574-16-7 | Details |
| EP12 | C26H22FN3O2 | 2882916-73-4 | Details |
| BC-05 | C21H29BN2O9 | 2260717-73-3 | Details |
| Smurf1-IN-1 | C24H29ClN6O2 | 1824708-03-3 | Details |
| Dim16 | C29H38IN5 | 2743448-32-8 | Details |
| hnNOS-IN-2 | C18H23F2N3 | 2700326-00-5 | Details |
| Keap1-Nrf2-IN-15 | 2456295-45-5 | Details |
| HIV-1 inhibitor-57 | C25H24FN5O3S | 2745197-24-2 | Details |
| ZINC475239213 | C21H15N5O2 | 2871002-89-8 | Details |
| AJH-836 | C22H38O5 | 388621-67-8 | Details |
| J-1048 | C23H17FN6S2 | 2374772-60-6 | Details |
| HDAC-IN-63 | C25H26Cl2N6O3 | 2920046-95-1 | Details |
| YIAD-0205 | C26H16Br2ClN3 | 2446054-34-6 | Details |
| SIRT5 inhibitor 6 | C21H28N6O4S | 2834736-82-0 | Details |
| S-F24 | C25H27BrF2N6O | 2946669-78-7 | Details |
| LSD1-UM-109 | C29H27FN6 | 2252446-26-5 | Details |
| HDAC-IN-58 | C16H13ClF2N4O3S | 2071224-39-8 | Details |
| Quorum Sensing-IN-2 | C19H13F2NO3 | 2925926-80-1 | Details |
| EGFR-IN-82 | C32H41BrN9O2P | 2568086-81-5 | Details |
| MY-673 | C18H14N2O4 | 2944459-96-3 | Details |
| IDO1-IN-21 | 2892432-98-1 | Details |
| SJ1461 | C21H18ClN7OS2 | 2924546-70-1 | Details |
| BRD4 Inhibitor-28 | C23H21N3O3 | 2468960-80-5 | Details |
| Antitubercular agent-37 | C22H22N8O2 | 21696-12-8 | Details |
| MmpL3-IN-3 | C26H33ClN2Si | 1639438-67-7 | Details |
| BChE/HDAC6-IN-1 | C34H43N5O5 | 2925457-27-6 | Details |
| Aurora Kinases-IN-4 | C26H28N8O | 2877011-84-0 | Details |
| IL-1β-IN-2 | 2242896-76-8 | Details |
| Neuraminidase-IN-13 | 2222067-23-2 | Details |
| NS2B/NS3-IN-3 hydrochloride | C19H21N3O2.ClH | 2832876-91-0 | Details |
| Erythronic acid | C4H8O5 | 13752-84-6 | Details |
| U-89843A | C16H24ClN5 | 157013-85-9 | Details |
| PDE7-IN-3 | C18H21ClN2O4 | 908570-13-8 | Details |
| EGFR-IN-85 | C26H30N8O2 | 1956378-29-2 | Details |
| Anti-amyloid agent-1 | C21H17F3N2O3 | 1396778-73-6 | Details |
| M62812 free base | C13H11N3OS | 613262-61-6 | Details |
| SRI 6409-94 | C24H29NO3 | 127697-58-9 | Details |
| Anticancer agent 164 | C21H23F3N8O2S2 | 2235393-30-1 | Details |
| HPK1-IN-35 | C30H32N8O3S | 2935903-77-6 | Details |
| Nrf2 activator-7 | 2456295-39-7 | Details |
| SHP2-IN-13 | C16H21N7O | 2951854-02-5 | Details |
| LTB4 antagonist 2 | C26H23NO6 | 2929239-85-8 | Details |
| Antileishmanial agent-14 | 1638956-72-5 | Details |
| LTB4 antagonist 3 | C29H27NO6 | 2929239-87-0 | Details |
| Chitin synthase inhibitor 14 | C25H26ClN5O5 | 2922114-19-8 | Details |
| TWIK-1/TREK-1-IN-2 | C20H29F3N2O2 | 1440532-32-0 | Details |
| NLRP3-IN-21 | C20H13Cl2F3N6O2S | 2956791-61-8 | Details |
| CDK/HDAC-IN-3 | C24H18Cl2N6O3 | 2944087-54-9 | Details |
| TWIK-1/TREK-1-IN-1 | C21H24F3NO3 | 1440532-30-8 | Details |
| SIRT5 inhibitor 7 | C28H32ClN7O3S | 2951090-00-7 | Details |
| DNA gyrase B-IN-3 | C14H9Cl2N3O4S | 2412834-56-9 | Details |
| SIKs-IN-1 | C27H31F2N7O | 2927557-06-8 | Details |
| Yhhu6669 | C29H28ClFN6O3 | 2569526-80-1 | Details |
| OPC-163493 | C14H8F3N5S | 1644467-84-4 | Details |
| SLC26A3-IN-3 | C20H17IO5 | 2369983-43-5 | Details |
| Z-LLF-CHO | C29H39N3O5 | 133429-58-0 | Details |
| BTM-3528 | C24H19F4N3O2S2 | 2054998-45-5 | Details |
| (R)-VX-11e | C24H20Cl2FN5O2 | 1680187-43-2 | Details |
| MC-VA-PAB-Exatecan | C50H54FN7O11 | 2680543-57-9 | Details |
| JNJ-1013 | C46H55N9O7S | 2597343-08-1 | Details |
| BODIPY FL thalidomide | C37H43BF2N6O7 | 2740620-18-0 | Details |
| MAO-B-IN-23 | C19H18BrNO | 2107978-22-1 | Details |
| RET-IN-22 | C29H31F3N6O4 | 2918281-79-3 | Details |
| A-77636 | C20H27NO3 | 778546-51-3 | Details |
| Tubulin inhibitor 33 | C24H22N4O3 | 2944462-67-1 | Details |
| Anticancer agent 110 | C18H13FN6OS | 887349-03-3 | Details |
| TH-Z835 | C30H38N6O | 2766209-50-9 | Details |
| Ac-Exatecan | C26H24FN3O5 | 2922852-48-8 | Details |
| CS640 | C21H31N7O | 2388506-83-8 | Details |
| SHP2-IN-5 | C12H8O6 | 54755-93-0 | Details |
| Xilmenolone | C26H37N3O2 | 2368807-26-3 | Details |
| SDH-IN-5 | C16H19F2N3O2 | 2922765-95-3 | Details |
| α-Synuclein inhibitor 9 | C27H24O4 | 1510825-03-2 | Details |
| MMP13-IN-4 | C21H17BrN4O5 | 514855-02-8 | Details |
| (R)-Azasetron besylate | C17H20ClN3O3.C6H6O3S | 2025360-91-0 | Details |
| Cholesterol nervonate | C51H90O2 | 60758-73-8 | Details |
| Leramistat | C20H21ClN2O3S | 1642602-54-7 | Details |
| Aβ/tau aggregation-IN-3 | C23H22N4O3 | 1210750-32-5 | Details |
| Brazilein | C16H12O5 | 600-76-0 | Details |
| Dihydro-5-azacytidine acetate | 2470972-18-8 | Details |
| CK2-IN-9 | C23H29N9O | 1461658-58-1 | Details |
| Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 | C30H58N10O12 | 2244602-35-3 | Details |
| E235 | C28H25FN4OS | 891894-69-2 | Details |
| Product Total： Product Page： | ||||
| 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 | ||||